 effect recombin human erythropoietin cerebr cutan blood flow blood coagul seizur hypertens encephalopathi transient ischem attack thrombosi hemodialysi access earli clinic trial recombin human erythropoietin event hematocrit valu direct effect recombin human hormon transfusion-depend hemodialysi patient group serum ferritin concentr group microgram/lit group micrograms/lit month placebo administr recombin human erythropoietin u/kg month month hematocrit valu mean SD dose adjust group thrice weekli phlebotomi group constant dose erythropoietin viscos subnorm normal group cerebr blood flow normal normal group minor insignific chang viscos reciproc chang cerebr blood flow chang group transcutan oxygen tension bleed time normal group recombin human erythropoietin administr chang statist signific fibrinogen level patient unchang signific coagulation-rel chang recombin erythropoietin dosag schedul administr studi chang seizur intravascular thrombosi